Variant report

Variant	nsv1054109
Chromosome Location	chr11:104948117-104976058
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BATF	chr11:104970890-104971077	GM12878	blood:	n/a	n/a
2	BATF	chr11:104948119-104948459	GM12878	blood:	n/a	chr11:104948321-104948332
3	CEBPB	chr11:104948635-104948827	HepG2	liver:	n/a	chr11:104948658-104948669
4	CEBPB	chr11:104951117-104951358	IMR90	lung:	n/a	n/a
5	CEBPB	chr11:104951169-104951316	Hela-S3	cervix:	n/a	n/a
6	CTCF	chr11:104963680-104963830	HMEC	breast:	n/a	n/a
7	CTCF	chr11:104971768-104971837	GM10266	blood:	n/a	n/a
8	CTCF	chr11:104972751-104972831	Spleen_OC	spleen:	n/a	n/a
9	CTCF	chr11:104963760-104963910	HPAF	blood vessel:	n/a	n/a
10	CTCF	chr11:104963580-104963730	HMEC	breast:	n/a	n/a
11	CTCF	chr11:104965975-104966006	GM20000	blood:	n/a	n/a
12	CTCF	chr11:104948711-104948822	Kidney_OC	kidney:	n/a	n/a
13	FOS	chr11:104971940-104972376	MCF10A-Er-Src	breast:	n/a	n/a
14	FOS	chr11:104970870-104971415	MCF10A-Er-Src	breast:	n/a	chr11:104971220-104971230 chr11:104971217-104971228 chr11:104971220-104971230 chr11:104971221-104971230
15	FOS	chr11:104963677-104964022	HUVEC	blood vessel:	n/a	chr11:104963836-104963847 chr11:104963838-104963845 chr11:104963838-104963846 chr11:104963838-104963847 chr11:104963837-104963846
16	FOS	chr11:104970835-104971425	MCF10A-Er-Src	breast:	n/a	chr11:104971220-104971230 chr11:104971217-104971228 chr11:104971220-104971230 chr11:104971221-104971230
17	FOS	chr11:104970836-104971491	MCF10A-Er-Src	breast:	n/a	chr11:104971220-104971230 chr11:104971217-104971228 chr11:104971220-104971230 chr11:104971221-104971230
18	FOS	chr11:104948928-104949030	MCF10A-Er-Src	breast:	n/a	n/a
19	FOS	chr11:104970925-104971329	MCF10A-Er-Src	breast:	n/a	chr11:104971220-104971230 chr11:104971217-104971228 chr11:104971220-104971230 chr11:104971221-104971230
20	FOS	chr11:104963304-104963925	MCF10A-Er-Src	breast:	n/a	chr11:104963836-104963847 chr11:104963362-104963369 chr11:104963838-104963845 chr11:104963838-104963846 chr11:104963838-104963847 chr11:104963837-104963846
21	FOS	chr11:104963328-104963986	MCF10A-Er-Src	breast:	n/a	chr11:104963836-104963847 chr11:104963362-104963369 chr11:104963838-104963845 chr11:104963838-104963846 chr11:104963838-104963847 chr11:104963837-104963846
22	FOS	chr11:104971878-104972346	MCF10A-Er-Src	breast:	n/a	chr11:104971936-104971945
23	FOS	chr11:104972012-104972419	MCF10A-Er-Src	breast:	n/a	n/a
24	FOS	chr11:104963304-104963982	MCF10A-Er-Src	breast:	n/a	chr11:104963836-104963847 chr11:104963362-104963369 chr11:104963838-104963845 chr11:104963838-104963846 chr11:104963838-104963847 chr11:104963837-104963846
25	FOS	chr11:104948241-104948837	MCF10A-Er-Src	breast:	n/a	n/a
26	FOS	chr11:104948262-104948729	MCF10A-Er-Src	breast:	n/a	n/a
27	FOS	chr11:104970874-104971326	HUVEC	blood vessel:	n/a	chr11:104971220-104971230 chr11:104971217-104971228 chr11:104971220-104971230 chr11:104971221-104971230
28	FOS	chr11:104972042-104972303	MCF10A-Er-Src	breast:	n/a	n/a
29	FOS	chr11:104948211-104948907	MCF10A-Er-Src	breast:	n/a	n/a
30	FOXA2	chr11:104960656-104960851	HepG2	liver:	n/a	n/a
31	GATA2	chr11:104970412-104971122	HUVEC	blood vessel:	n/a	chr11:104970654-104970665 chr11:104970652-104970661 chr11:104971022-104971032 chr11:104970575-104970585
32	GATA2	chr11:104963362-104963700	SH-SY5Y	brain:	n/a	chr11:104963445-104963455
33	GATA3	chr11:104963367-104963635	MCF-7	breast:	n/a	chr11:104963445-104963455
34	GATA3	chr11:104963287-104963717	SH-SY5Y	brain:	n/a	chr11:104963445-104963455
35	JUND	chr11:104971147-104971315	H1-hESC	embryonic stem cell:	n/a	chr11:104971220-104971230 chr11:104971217-104971228 chr11:104971220-104971230 chr11:104971221-104971230
36	MAZ	chr11:104963309-104963476	HepG2	liver:	n/a	n/a
37	MYC	chr11:104970971-104971322	MCF10A-Er-Src	breast:	n/a	n/a
38	MYC	chr11:104963252-104963831	MCF10A-Er-Src	breast:	n/a	n/a
39	MYC	chr11:104971795-104972416	MCF10A-Er-Src	breast:	n/a	n/a
40	MYC	chr11:104948580-104948902	MCF10A-Er-Src	breast:	n/a	n/a
41	MYC	chr11:104970915-104971322	MCF10A-Er-Src	breast:	n/a	n/a
42	MYC	chr11:104971999-104972414	MCF10A-Er-Src	breast:	n/a	n/a
43	MYC	chr11:104963215-104963761	MCF10A-Er-Src	breast:	n/a	n/a
44	MYC	chr11:104970534-104970664	HUVEC	blood vessel:	n/a	n/a
45	MYC	chr11:104948687-104948837	MCF10A-Er-Src	breast:	n/a	n/a
46	POLR2A	chr11:104951944-104951960	GM12878	blood:	n/a	n/a
47	POLR2A	chr11:104971978-104972500	MCF10A-Er-Src	breast:	n/a	n/a
48	POLR2A	chr11:104964158-104964302	MCF10A-Er-Src	breast:	n/a	n/a
49	POLR2A	chr11:104971071-104971566	MCF10A-Er-Src	breast:	n/a	n/a
50	POLR2A	chr11:104949545-104949721	MCF10A-Er-Src	breast:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:104972078-104972128	ECC-1	luminal epithelium:	n/a
2	chr11:104972078-104972128	ECC-1	luminal epithelium:	n/a
3	chr11:104972078-104972128	Jurkat	blood:	n/a
4	chr11:104972907-104972957	BE2_C	brain:	n/a
5	chr11:104972078-104972128	MCF-7	breast:	n/a
6	chr11:104972474-104972524	AG09309	skin:	n/a
7	chr11:104966249-104966299	GM12892	blood:	n/a
8	chr11:104972907-104972957	GM12878	blood:	n/a
9	chr11:104972078-104972128	H1-hESC	embryonic stem cell:	embryo
10	chr11:104972135-104972185	PANC-1	pancreas:	n/a
11	chr11:104972907-104972957	ProgFib	skin:	n/a
12	chr11:104972474-104972524	HRCEpiC	kidney:	n/a
13	chr11:104966249-104966299	T-47D	breast:	n/a
14	chr11:104973640-104973690	H1-hESC	embryonic stem cell:	embryo
15	chr11:104973640-104973690	SK-N-SH	brain:	n/a
16	chr11:104972078-104972128	RPTEC	kidney:	n/a
17	chr11:104966249-104966299	NH-A	brain:	n/a
18	chr11:104973640-104973690	HCM	heart:	n/a
19	chr11:104972907-104972957	HRCEpiC	kidney:	n/a
20	chr11:104966249-104966299	U87	brain:	n/a
21	chr11:104972078-104972128	Hela-S3	cervix:	n/a
22	chr11:104972078-104972128	AG10803	skin:	n/a
23	chr11:104966249-104966299	AG10803	skin:	n/a
24	chr11:104972135-104972185	Caco-2	colon:	n/a
25	chr11:104972078-104972128	HEEpiC	esophagus:	n/a
26	chr11:104972135-104972185	Jurkat	blood:	n/a
27	chr11:104972907-104972957	ECC-1	luminal epithelium:	n/a
28	chr11:104972474-104972524	NH-A	brain:	n/a
29	chr11:104972135-104972185	HepG2	liver:	n/a
30	chr11:104966249-104966299	SK-N-SH_RA	brain:	n/a
31	chr11:104966249-104966299	HPAEpiC	pulmonary alveolar:	n/a
32	chr11:104973640-104973690	Jurkat	blood:	n/a
33	chr11:104973640-104973690	HMEC	breast:	n/a
34	chr11:104972474-104972524	PFSK-1	brain:	n/a
35	chr11:104972135-104972185	HMEC	breast:	n/a
36	chr11:104972907-104972957	HCT-116	colon:	n/a
37	chr11:104973640-104973690	HRCEpiC	kidney:	n/a
38	chr11:104972907-104972957	HRE	kidney:	n/a
39	chr11:104972907-104972957	GM12892	blood:	n/a
40	chr11:104966249-104966299	HCF	heart:	n/a
41	chr11:104966249-104966299	AoSMC	blood vessel:	n/a
42	chr11:104966249-104966299	HL-60	blood:	n/a
43	chr11:104966249-104966299	HRE	kidney:	n/a
44	chr11:104972078-104972128	HCPEpiC	choroid plexus:	n/a
45	chr11:104966249-104966299	K562	blood:	n/a
46	chr11:104972135-104972185	BJ	skin:	n/a
47	chr11:104972078-104972128	K562	blood:	n/a
48	chr11:104972907-104972957	PrEC	prostate:	n/a
49	chr11:104972474-104972524	PANC-1	pancreas:	n/a
50	chr11:104972907-104972957	HAEpiC	amniotic membrane:	n/a

Variant related genes	Relation type
CASP1	TF binding region
CARD16	TF binding region
CARD17	TF binding region
CASP1	CpG island
CARD16	CpG island
CARD17	CpG island

Extended variants
information (count: 1025 )
Associated
traits (count: 92 )

Variant overlapped rSNPs/rCNVs (count:1025 , 50 per page) page: 1 2 3 4 5 6 7 ... 21

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs114469646	chr11:104948119-104948120	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs372846705	chr11:104948128-104948129	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs138991883	chr11:104948201-104948202	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs528140543	chr11:104948203-104948204	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs375105329	chr11:104948228-104948229	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs551110154	chr11:104948269-104948270	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs571225441	chr11:104948272-104948273	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs112495464	chr11:104948282-104948283	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs113168687	chr11:104948301-104948302	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs570312585	chr11:104948305-104948306	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs535663621	chr11:104948316-104948317	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs572422134	chr11:104948347-104948348	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs555890864	chr11:104948371-104948372	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs556191924	chr11:104948377-104948378	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs149958611	chr11:104948394-104948395	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs2509638	chr11:104948420-104948421	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs2455785	chr11:104948423-104948424	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs541486869	chr11:104948459-104948460	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs386757117	chr11:104948493-104948494	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs508149	chr11:104948494-104948495	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs373383352	chr11:104948505-104948506	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs181380351	chr11:104948546-104948547	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs10528808	chr11:104948550-104948551	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs1785890	chr11:104948552-104948553	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs371585367	chr11:104948554-104948555	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs374883885	chr11:104948556-104948557	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs369859900	chr11:104948558-104948559	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs373014672	chr11:104948560-104948561	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs377514664	chr11:104948562-104948563	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs369873100	chr11:104948564-104948565	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs58361756	chr11:104948566-104948567	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs56826482	chr11:104948568-104948569	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs60769243	chr11:104948578-104948579	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs1699092	chr11:104948579-104948580	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs12804837	chr11:104948602-104948603	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs4755067	chr11:104948617-104948618	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs10668195	chr11:104948618-104948619	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs542460100	chr11:104948621-104948622	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs1699093	chr11:104948623-104948624	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs559469139	chr11:104948634-104948635	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs7935149	chr11:104948688-104948689	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs490824	chr11:104948695-104948696	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
43	rs571288879	chr11:104948729-104948730	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs7128798	chr11:104948777-104948778	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs530518253	chr11:104948791-104948792	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs10581634	chr11:104948846-104948847	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs550537535	chr11:104948847-104948848	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs71471746	chr11:104948850-104948851	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs570376450	chr11:104948856-104948857	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs492519	chr11:104948857-104948858	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:92)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Acute myeloid leukemia	20729466	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Cervical cancer	21062161	CNVD
Esophageal squamous carcinoma	18350619	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	22429812	CNVD
Breast cancer	16608533	CNVD
T-cell lymphomas	19863542	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Basal cell lymphoma	17053054	CNVD
Hepatocellular carcinoma	16785998	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21785460	CNVD
Breast cancer	21958427	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	17133270	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	17603634	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Basal cell lymphoma	16790693	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Breast cancer	21364760	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Mental retardation	19966786	CNVD
Non-small cell lung cancer	21829676	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Intracranial aneurysm	16715129	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Urothelial carcinoma	21177765	CNVD
Myelofibrosis	22110671	CNVD
Ovarian cancer	21720365	CNVD
Chronic lymphocytic leukemia	17805327	CNVD
Glioblastoma multiforme	22286061	CNVD
Breast cancer	16397240	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Neuroblastoma	17327916	CNVD
Melanoma	17363583	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Mantle cell lymphoma	19029149	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Malignant melanoma	17260012	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Prostate cancer	16573809	CNVD
Obesity	19966786	CNVD
Prostate cancer	18632612	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:223 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:104942600-104948200	Weak transcription	NHEK	skin
2	chr11:104943000-104950000	Weak transcription	Monocytes-CD14+_RO01746	blood
3	chr11:104943200-104948600	Weak transcription	Primary monocytes fromperipheralblood	blood
4	chr11:104945400-104950800	Weak transcription	HUVEC	blood vessel
5	chr11:104946200-104949000	Weak transcription	Psoas Muscle	Psoas
6	chr11:104947400-104949400	Enhancers	Skeletal Muscle Female	skeletal muscle
7	chr11:104947600-104949400	Enhancers	HMEC	breast
8	chr11:104948000-104948200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
9	chr11:104948000-104949200	Enhancers	Adipose Nuclei	Adipose
10	chr11:104948000-104949400	Enhancers	Skeletal Muscle Male	skeletal muscle
11	chr11:104948000-104953200	Enhancers	Breast Myoepithelial Primary Cells	Breast
12	chr11:104948200-104949000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
13	chr11:104948200-104949400	Enhancers	NHEK	skin
14	chr11:104948600-104949000	Enhancers	Primary monocytes fromperipheralblood	blood
15	chr11:104948800-104949200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
16	chr11:104949000-104949400	Enhancers	Psoas Muscle	Psoas
17	chr11:104949000-104950200	Weak transcription	Primary monocytes fromperipheralblood	blood
18	chr11:104949200-104949400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
19	chr11:104949200-104951000	Weak transcription	Adipose Nuclei	Adipose
20	chr11:104949400-104950800	Weak transcription	NHEK	skin
21	chr11:104950000-104950200	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
22	chr11:104950000-104950400	Enhancers	Monocytes-CD14+_RO01746	blood
23	chr11:104950200-104950800	Enhancers	Primary monocytes fromperipheralblood	blood
24	chr11:104950200-104951000	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
25	chr11:104950200-104953400	Enhancers	Cortex derived primary cultured neurospheres	brain
26	chr11:104950400-104950600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
27	chr11:104950400-104950800	Enhancers	Right Atrium	heart
28	chr11:104950400-104951200	Enhancers	Small Intestine	intestine
29	chr11:104950400-104951400	Enhancers	Primary hematopoietic stem cells short term culture	blood
30	chr11:104950400-104951800	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
31	chr11:104950400-104952000	Enhancers	iPS-15b Cell Line	embryonic stem cell
32	chr11:104950400-104952200	Enhancers	iPS-18 Cell Line	embryonic stem cell
33	chr11:104950600-104950800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
34	chr11:104950600-104951000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
35	chr11:104950600-104951800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
36	chr11:104950600-104951800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
37	chr11:104950600-104952400	Enhancers	iPS-20b Cell Line	embryonic stem cell
38	chr11:104950600-104953800	Enhancers	HUES48 Cell Line	embryonic stem cell
39	chr11:104950800-104951000	Enhancers	H1 Cell Line	embryonic stem cell
40	chr11:104950800-104951000	Enhancers	H9 Cell Line	embryonic stem cell
41	chr11:104950800-104951000	Enhancers	HUES64 Cell Line	embryonic stem cell
42	chr11:104950800-104951000	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
43	chr11:104950800-104951000	Enhancers	Duodenum Mucosa	Duodenum
44	chr11:104950800-104951000	Weak transcription	Right Atrium	heart
45	chr11:104950800-104951200	Flanking Active TSS	Primary monocytes fromperipheralblood	blood
46	chr11:104950800-104951200	Enhancers	Primary neutrophils fromperipheralblood	blood
47	chr11:104950800-104951200	Enhancers	Fetal Intestine Large	intestine
48	chr11:104950800-104951200	Enhancers	NHEK	skin
49	chr11:104950800-104951400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
50	chr11:104950800-104951600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links